200 related articles for article (PubMed ID: 27098106)
1. Expression and Activity of Metalloproteinases in Depression.
Bobińska K; Szemraj J; Czarny P; Gałecki P
Med Sci Monit; 2016 Apr; 22():1334-41. PubMed ID: 27098106
[TBL] [Abstract][Full Text] [Related]
2. Role of MMP-2, MMP-7, MMP-9 and TIMP-2 in the development of recurrent depressive disorder.
Bobińska K; Szemraj J; Czarny P; Gałecki P
J Affect Disord; 2016 Nov; 205():119-129. PubMed ID: 27434116
[TBL] [Abstract][Full Text] [Related]
3. Involvement of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the chicken oviduct regression and recrudescence.
Leśniak-Walentyn A; Hrabia A
Cell Tissue Res; 2016 Nov; 366(2):443-454. PubMed ID: 27342592
[TBL] [Abstract][Full Text] [Related]
4. Expression of matrix metalloproteinases (MMP-2, MMP-9, MT1-MMP) and their inhibitors (TIMP-1, TIMP-2) in common epithelial tumors of the ovary.
Sakata K; Shigemasa K; Nagai N; Ohama K
Int J Oncol; 2000 Oct; 17(4):673-81. PubMed ID: 10995877
[TBL] [Abstract][Full Text] [Related]
5. Expression of matrix metalloproteinases and tissue inhibitors of metalloproteinases in human optic nerve head astrocytes.
Agapova OA; Ricard CS; Salvador-Silva M; Hernandez MR
Glia; 2001 Mar; 33(3):205-16. PubMed ID: 11241738
[TBL] [Abstract][Full Text] [Related]
6. Expression and localization of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the chicken oviduct during pause in laying induced by tamoxifen.
Leśniak-Walentyn A; Hrabia A
Theriogenology; 2017 Jan; 88():50-60. PubMed ID: 27865412
[TBL] [Abstract][Full Text] [Related]
7. Involvement of matrix metalloproteinases (MMP-2, -7, -9) and their tissue inhibitors (TIMP-2, -3) in the regression of chicken postovulatory follicles.
Hrabia A; Socha JK; Sechman A
Gen Comp Endocrinol; 2018 May; 260():32-40. PubMed ID: 29438675
[TBL] [Abstract][Full Text] [Related]
8. Association analysis of genetic polymorphisms and expression levels of selected genes involved in extracellular matrix turnover and angiogenesis with the risk of age-related macular degeneration.
Oszajca K; Szemraj M; Szemraj J; Jurowski P
Ophthalmic Genet; 2018 Dec; 39(6):684-698. PubMed ID: 30289322
[TBL] [Abstract][Full Text] [Related]
9. The role of MMP genes in recurrent depressive disorders and cognitive functions.
Bobińska K; Szemraj J; Gałecki P; Talarowska M
Acta Neuropsychiatr; 2016 Aug; 28(4):221-31. PubMed ID: 26856768
[TBL] [Abstract][Full Text] [Related]
10. [Significance of imbalance between matrix metalloproteinases and tissue type inhibitor of metalloproteinases in renal tubulointerstitial lesions of aging rats].
Chen RQ; Chen XM; Cui SW; Cai GY; Shi SZ; Xie YS; Lu Y; Peng LX
Zhonghua Yi Xue Za Zhi; 2004 Jun; 84(11):937-42. PubMed ID: 15329283
[TBL] [Abstract][Full Text] [Related]
11. Dynamic expression of mRNAs and proteins for matrix metalloproteinases and their tissue inhibitors in the primate corpus luteum during the menstrual cycle.
Young KA; Hennebold JD; Stouffer RL
Mol Hum Reprod; 2002 Sep; 8(9):833-40. PubMed ID: 12200461
[TBL] [Abstract][Full Text] [Related]
12. The selected genetic polymorphisms of metalloproteinases MMP2, 7, 9 and MMP inhibitor TIMP2 in sarcoidosis.
Piotrowski WJ; Górski P; Pietras T; Fendler W; Szemraj J
Med Sci Monit; 2011 Oct; 17(10):CR598-607. PubMed ID: 21959615
[TBL] [Abstract][Full Text] [Related]
13. [Expression of matrix metalloproteinases-9,2,7,and tissue inhibitor of metalloproteinases-1,2,3 mRNA in ovarian tumors and their clinical significance].
Hu XX; Li L; Li DR; Zhang W; Cheng XQ; Zhang JQ; Tang BJ
Ai Zheng; 2004 Oct; 23(10):1194-8. PubMed ID: 15473934
[TBL] [Abstract][Full Text] [Related]
14. Regulation of matrix metalloproteinases and tissue inhibitors of matrix metalloproteinases by Porphyromonas gingivalis in an engineered human oral mucosa model.
Andrian E; Mostefaoui Y; Rouabhia M; Grenier D
J Cell Physiol; 2007 Apr; 211(1):56-62. PubMed ID: 17226791
[TBL] [Abstract][Full Text] [Related]
15. Tamoxifen-induced alterations in the expression of selected matrix metalloproteinases (MMP-2, -9, -10, and -13) and their tissue inhibitors (TIMP-2 and -3) in the chicken ovary.
Wolak D; Hrabia A
Theriogenology; 2020 May; 148():208-215. PubMed ID: 31753476
[TBL] [Abstract][Full Text] [Related]
16. Induction of matrix metalloproteinases (MMPs) and tissue inhibitors of MMPs correlates with outcome of acute experimental pseudomonal keratitis.
Ikema K; Matsumoto K; Inomata Y; Komohara Y; Miyajima S; Takeya M; Tanihara H
Exp Eye Res; 2006 Dec; 83(6):1396-404. PubMed ID: 16968651
[TBL] [Abstract][Full Text] [Related]
17. Effect of eCG treatment on gene expression of selected matrix metalloproteinases (MMP-2, MMP-7, MMP-9, MMP-10, and MMP-13) and the tissue inhibitors of metalloproteinases (TIMP-2 and TIMP-3) in the chicken ovary.
Wolak D; Sechman A; Hrabia A
Anim Reprod Sci; 2021 Jan; 224():106666. PubMed ID: 33260067
[TBL] [Abstract][Full Text] [Related]
18. Expression of tissue levels of matrix metalloproteinases and their inhibitors in breast cancer.
Zhang M; Teng XD; Guo XX; Li ZG; Han JG; Yao L
Breast; 2013 Jun; 22(3):330-4. PubMed ID: 22995648
[TBL] [Abstract][Full Text] [Related]
19. Matrix metalloproteinase expression and activity following prostaglandin F(2 alpha)-induced luteolysis.
Ricke WA; Smith GW; Smith MF
Biol Reprod; 2002 Mar; 66(3):685-91. PubMed ID: 11870075
[TBL] [Abstract][Full Text] [Related]
20. [Expression and significance of matrix metalloproteinase and tissue inhibitor of matrix metalloproteinase in non-melanoma skin cancer].
Fu XR; Zhang C; Chen CY; Zhang L; Wang LX; Wang BH; Liu XY; Zhang MZ
Zhonghua Zhong Liu Za Zhi; 2012 May; 34(5):369-73. PubMed ID: 22883459
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
